Pilot Study of Edaravone to Treat Acute Myocardial Infarction

Summary

Early reperfusion therapy has improved the clinical outcomes of patients with acute myocardial infarction (AMI), but these benefits are limited in some patients by reperfusion injuries. There is now increasing evidence that reactive oxygen species cause reperfusion injury. This study was designed to examine the effects of edaravone, a novel free radical scavenger, in patients with AMI.

Timeline

Start

2001-04

Primary completion

—

Completion

2007-06

Drugs

Indications